Sandro Esteves: APHRODITE Criteria for More Targeted Male Infertility Care
Sandro Esteves, Honorary Professor of Reproductive Medicine at Aarhus University, shared a post on LinkedIn:
“Despite advances in ART, many men are still managed with oral agents prescribed without a clear endocrine rationale, often with variable and modest effects. This approach contrasts sharply with what we have learned in female reproductive medicine, where treatment evolved toward physiology-driven strategies.
In this opinion article co-authored with Peter Humaidan, we revisit that gap and argue that the field is ready for a shift.
The APHRODITE criteria integrate patient clinical characteristics, endocrine phenotype, and spermatogenic status to align treatment with underlying biology rather than empirical convention.
A key implication is the repositioning of gonadotropins—not as a last resort, but as a rational, earlier-line option in selected patients. Unlike oral agents (e.g., SERMS, AIs), gonadotropins act directly at the testicular level, restoring the physiological drivers of spermatogenesis.
This is not about replacing one treatment with another.
It is about abandoning non-stratified care.
As in ovarian stimulation, progress in male infertility will likely depend on recognizing that biological heterogeneity matters—and that treatment should follow phenotype, not habit.
The next step is clear: prospective evidence built around APHRODITE-defined phenotypes. Until then, continuing purely empirical therapy without phenotyping may no longer be justifiable.”
Title: From tablets to targeted therapy: the APHRODITE era in male infertility
Authors:Sandro C Esteves , Peter Humaidan
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 25, 2026, 08:14How RNF216 Variants Link Dementia, Hypogonadism and Severe Ataxia – SEF
-
Apr 25, 2026, 07:55Geoffroy Robin: Diagnostic Value of ACTH Stimulation Test in NCAH Evaluation
-
Apr 25, 2026, 07:44Christopher Robinson: Transplantation Parallels in Pregnancy Immune Disorders
-
Apr 25, 2026, 06:21Silymarin Protects Male Fertility During Chemotherapy – Fertility and Sterility
-
Apr 25, 2026, 05:56ESHRE Opens Registration for Two-Day Scientific Speed Dating at ESHRE2026
-
Apr 25, 2026, 05:48Antonio Requena Miranda: When the Endometrium Is “Older” Than the Patient
-
Apr 25, 2026, 05:43Marco Zaccaria: From Dragon Legends to Medical Breakthroughs in ART
-
Apr 25, 2026, 05:40FOXO1 and Progesterone Receptor Expression in Endometrial Epithelial Cells at Embryo Transfer Time – Fertility and Sterility
-
Apr 25, 2026, 05:37Does the Age of Your Culture Media Actually Impact IVF Outcomes? – ESHRE